These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1530 related articles for article (PubMed ID: 26181180)

  • 1. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
    Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
    Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Hillyer GC; Chen L; Hershman DL
    Breast Cancer Res Treat; 2016 Jul; 158(2):373-84. PubMed ID: 27365080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.
    Huang NS; Si J; Yang BL; Quan CL; Chen JJ; Wu J
    Cancer Med; 2018 Jan; 7(1):56-63. PubMed ID: 29271113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
    Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
    Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.
    Miller ME; Kyrillos A; Yao K; Kantor O; Tseng J; Winchester DJ; Shulman LN
    Ann Surg Oncol; 2016 Oct; 23(10):3337-46. PubMed ID: 27334212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
    Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
    Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
    Pilewskie M; Karsten M; Radosa J; Eaton A; King TA
    Ann Surg Oncol; 2016 Jul; 23(7):2229-34. PubMed ID: 26960927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Axillary Staging in the Management of Ductal Carcinoma In Situ.
    Van Zee KJ
    JAMA Oncol; 2015 Jun; 1(3):332-3. PubMed ID: 26181181
    [No Abstract]   [Full Text] [Related]  

  • 15. [A single-center retrospective study on axillary evaluation in 1 557 breast ductal carcinoma in situ patients between 2006 and 2016].
    Si J; Quan CL; Mo M; Guo R; Su YH; Yang BL; Chen JJ; Shao ZM; Wu J
    Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):681-685. PubMed ID: 31474060
    [No Abstract]   [Full Text] [Related]  

  • 16. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
    van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
    Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCIS and axillary nodal evaluation: compliance with national guidelines.
    Mitchell KB; Lin H; Shen Y; Colfry A; Kuerer H; Shaitelman SF; Babiera GV; Bedrosian I
    BMC Surg; 2017 Feb; 17(1):12. PubMed ID: 28173790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.